Lobel B - Search Results

1

Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma.

Rioux-Leclercq N, Turlin B, Bansard J, Patard J, Manunta A, Moulinoux JP, Guillé F, Ramée MP, Lobel B. Rioux-Leclercq N, et al. Among authors: lobel b. Urology. 2000 Apr;55(4):501-5. doi: 10.1016/s0090-4295(99)00550-6. Urology. 2000. PMID: 10736491

2

Intravesical Bacillus Calmette-Guerin treatment improves patient survival in T1G3 bladder tumours.

Patard JJ, Rodriguez A, Leray E, Rioux-Leclercq N, Guillé F, Lobel B. Patard JJ, et al. Among authors: lobel b. Eur Urol. 2002 Jun;41(6):635-41; discussion 642. doi: 10.1016/s0302-2838(02)00173-2. Eur Urol. 2002. PMID: 12074781

3

[Renal cell carcinoma before the age of 40: prognostic factors].

Moudouni S, En-Nia I, Rioux-Leclerq N, Bensalah K, Guille F, Lobel B, Patard JJ. Moudouni S, et al. Among authors: lobel b. Prog Urol. 2002 Sep;12(4):575-8. Prog Urol. 2002. PMID: 12463113 French.

4

Correlation between symptom graduation, tumor characteristics and survival in renal cell carcinoma.

Patard JJ, Leray E, Rodriguez A, Rioux-Leclercq N, Guillé F, Lobel B. Patard JJ, et al. Among authors: lobel b. Eur Urol. 2003 Aug;44(2):226-32. doi: 10.1016/s0302-2838(03)00216-1. Eur Urol. 2003. PMID: 12875943

5

Multi-institutional validation of a symptom based classification for renal cell carcinoma.

Patard JJ, Leray E, Cindolo L, Ficarra V, Rodriguez A, De La Taille A, Tostain J, Artibani W, Abbou CC, Guillé F, Chopin DK, Lobel B. Patard JJ, et al. Among authors: lobel b. J Urol. 2004 Sep;172(3):858-62. doi: 10.1097/01.ju.0000135837.64840.55. J Urol. 2004. PMID: 15310983

6

Immunohistochemical analysis of tumor polyamines discriminates high-risk patients undergoing nephrectomy for renal cell carcinoma.

Rioux-Leclercq N, Delcros JG, Bansard JY, Epstein JI, Patard JJ, Lobel B, Guillé F, Jouan F, Bellaud P, Moulinoux JP. Rioux-Leclercq N, et al. Among authors: lobel b. Hum Pathol. 2004 Oct;35(10):1279-84. doi: 10.1016/j.humpath.2004.07.002. Hum Pathol. 2004. PMID: 15492997

7

Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience.

Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, De La Taille A, Tostain J, Artibani W, Abbou CC, Lobel B, Guillé F, Chopin DK, Mulders PF, Wood CG, Swanson DA, Figlin RA, Belldegrun AS, Pantuck AJ. Patard JJ, et al. Among authors: lobel b. J Clin Oncol. 2005 Apr 20;23(12):2763-71. doi: 10.1200/JCO.2005.07.055. J Clin Oncol. 2005. PMID: 15837991

8

Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.

Klatte T, Patard JJ, Goel RH, Kleid MD, Guille F, Lobel B, Abbou CC, De La Taille A, Tostain J, Cindolo L, Altieri V, Ficarra V, Artibani W, Prayer-Galetti T, Allhoff EP, Schips L, Zigeuner R, Figlin RA, Kabbinavar FF, Pantuck AJ, Belldegrun AS, Lam JS. Klatte T, et al. Among authors: lobel b. J Urol. 2007 Jul;178(1):35-40; discussion 40. doi: 10.1016/j.juro.2007.03.046. Epub 2007 May 22. J Urol. 2007. PMID: 17521678

9

Erythrocyte polyamines and prognosis in stage D2 prostatic carcinoma patients.

Cipolla B, Guille F, Moulinoux JP, Bansard JY, Roth S, Staerman F, Corbel L, Quemener V, Lobel B. Cipolla B, et al. Among authors: lobel b. J Urol. 1994 Mar;151(3):629-33. doi: 10.1016/s0022-5347(17)35033-4. J Urol. 1994. PMID: 7508520

10

Polyamines and prostatic carcinoma: clinical and therapeutic implications.

Cipolla B, Guillé F, Moulinoux JP, Quemener V, Staerman F, Corbel L, Lobel B. Cipolla B, et al. Among authors: lobel b. Eur Urol. 1993;24(1):124-31. doi: 10.1159/000474279. Eur Urol. 1993. PMID: 7689970

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters